Press Release

View printer-friendly version

<<  Back

Streamline Health® Reports Third Quarter 2015 Financial Performance

ATLANTA, Dec. 10, 2015 /PRNewswire/ -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of transformational data-driven solutions to help healthcare providers reduce exposure to risk, enhance clinical, financial, and operational performance, and improve patient care, today announced financial results for the third quarter of 2015, which ended October 31, 2015.

Revenues for the three-month period ended October 31, 2015 declined as expected to approximately $7.2 million, as compared to $8.6 million in the previous quarter that included $1.6 million in perpetual license revenue.  Removing the revenue from the one-time perpetual license that was recognized in Q2, revenues for the year have increased consistently over the first three quarters of 2015, from $6.2 million in Q1, to $7.0 million in Q2, and to $7.2 million in Q3.  As compared to Q3 2014, revenues for Q3 2015 increased 5.9%.

Adjusted EBITDA for the third quarter 2015 was $1.7 million, up $2.0 million compared to Adjusted EBITDA from the third quarter of 2014. Adjusted EBITDA for the year-to-date period is $2.3 million, up $2.6 million from the comparable prior year period. On a GAAP basis, the company had a net loss of $0.5 million and $2.9 million for the three and nine months ended October 31, 2015, respectively.

The Company selected RSM US LLP (formerly known as McGladrey LLP) to replace KPMG LLP as its independent registered public accounting firm, effective today.  This change is expected to result in significant savings going forward.

"I'm pleased to report another solid quarter of performance.  We continue to realize significant improvement in our balance sheet, building cash and reducing debt as we look to improve our operational efficiency in all areas of our business," stated David Sides, President and Chief Executive Officer, Streamline Health.  "With the improvement in our financial position, we are now in position to invest significantly in our sales resources going forward by adding additional direct salespeople, account executives and a dedicated channel partner manager."

Highlights for the third quarter ended October 31, 2015 included:

  • Revenue for the third quarter 2015 was $7.2 million;
  • Adjusted EBITDA for the third quarter 2015 was $1.7 million;
  • Net loss for the third quarter 2015 was $0.5 million;
  • New sales bookings for the quarter were $1.1 million; and
  • Backlog at the end of the quarter was $67.5 million.

Conference Call Information

The Company will conduct a conference call to review the results on Thursday, December 10, 2015 at 5:00 PM ET. Interested parties can access the call by dialing 888-287-5563 and then entering passcode 1594783. A live webcast will also be available; click here to register.

A replay of the conference call will be available from Thursday, December 10, 2015 at 8:00 PM ET to Tuesday, December 15, 2015 at 8:00 PM ET by dialing 888-203-1112 and entering passcode 1594783.

About Streamline Health
Streamline Health Solutions, Inc. (NASDAQ: STRM) is a healthcare industry leader in capturing, aggregating, and translating enterprise data into knowledge­ - actionable insights that reduce exposure to risk, enhance operational performance, and improve patient care. Through our Looking Glass® Platform we provide clients with meaningful, intelligent SaaS-based solutions from patient engagement to reimbursement. We share a common calling and commitment to advance the quality of life and the quality of healthcare - for society, our industry, our clients, the communities they serve, and the individual patient. For more information, please visit our website at www.streamlinehealth.net.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995

Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements included herein. Forward-looking statements contained in this press release include, without limitation, statements regarding the Company's expected cost savings from changing its independent registered public accounting firm, debt, backlog, future investments in sales resources, and related expectations and assumptions.  These risks and uncertainties include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive solutions and pricing, solution demand and market acceptance, new solution development, key strategic alliances with vendors and channel partners that resell the Company's solutions, the ability of the Company to control costs, availability of solutions from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accounting Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry generally and the markets in which the Company operates and nationally, and the Company's ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

Company Contact:

Randy Salisbury
SVP, Chief Marketing Officer
(404) 229-4242
randy.salisbury@streamlinehealth.net

 

 

 


STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)




Three Months Ended


Nine Months Ended



Oct 31,


Oct 31,



2015


2014


2015


2014

Revenues:









  Systems sales

$

327,493

$

345,919

$

2,567,710

$

999,209

  Professional services


621,547


447,939


1,631,878


1,731,888

  Maintenance and support


4,034,481


4,062,442


11,315,664


12,411,419,

  Software as a service


2,171,548


1,980,343


6,428,358


5,887,368

        Total revenues


7,155,069


6,836,643


21,943,610


21,029,884










Operating expenses:









  Cost of systems sales


695,824


835,398


2,117,409


2,505,190

  Cost of professional services


829,964


681,350


2,249,029


2,446,466

  Cost of maintenance and support


766,594


756,469


2,297,772


2,553,180

  Cost of software as a service


611,158


770,347


2,052,758


2,113,390

  Selling, general and administrative


2,351,082


4,230,347


10,636,370


12,925,597

  Research and development


2,258,092


2,275,410


6,715,641


6,850,973

        Total operating expenses


7,512,714


9,549,321


26,068,979


29,394,796

Operating loss


(357,645)


(2,712,678)


(4,125,369)


(8,364,912)

Other income (expense):









  Interest expense


(206,286)


(180,583)


(698,402)


(523,599)

  Loss on early extinguishment of debt


--


(114,522)


--


(114,522)

  Miscellaneous income


110,383


752,219


1,939,543


1,803,509

Loss before income taxes


(453,548)


(2,255,564)


(2,884,228)


(7,199,524)

  Income tax expense


(3,113)


--


(2,645)


(2,290)

Net loss

$

(456,661)

$

(2,255,564)

$

(2,886,873)

$

(7,201,814)

Less: deemed dividends on Series A Preferred Shares


(346,339)


(269,152)


(967,014)


(751,501)

Net loss attributable to common shareholders

$

(803,000)

$

(2,524,716)

$

(3,853,887)

$

(7,953,315)

Basic net loss per common share

$

(0.04)

$

(0.14)

$

(0.21)

$

(0.44)

Number of shares used in basic per common share computation


18,746,632


18,309,677


18,658,626


18,210,034

Diluted net loss per common share

$

(0.04)

$

(0.14)

$

(0.21)

$

(0.44)

Number of shares used in diluted per common share computation


18,746,632


18,309,677


18,658,626


18,210,034

 

 

                               

STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)


Assets




October 31,

2015


January 31,

2015






Current assets:





  Cash and cash equivalents

$

8,505,736

$

6,522,600

  Accounts receivable, net of allowance for doubtful





    accounts of $130,214 and $665,962, respectively


3,429,188


6,935,270

  Contract receivables


142,250


191,465

  Prepaid hardware and third party software for





    future delivery


5,858


55,173

  Prepaid client maintenance contracts


1,048,667


935,858

  Other prepaid assets


1,084,721


1,437,680

  Deferred income taxes


220,004


220,004

  Other current assets


34,644


207,673

        Total current assets


14,471,068


16,505,723






Non-current assets:





Property and equipment:





  Computer equipment


2,507,132


2,381,923

  Computer software


677,354


964,857

  Office furniture, fixtures and equipment


683,443


683,443

  Leasehold improvements


729,348


724,015



4,597,277


4,754,238

  Accumulated depreciation and amortization


(2,103,282)


(1,617,423)

Property and equipment, net


2,493,995


3,136,815






 Contract receivables, less current portion


17,421


43,553

 Capitalized software development costs, net of





   accumulated amortization of $14,178,705 and





   $11,846,468, respectively


6,864,881


9,197,118

Intangible assets, net of accumulated amortization of





   $4,338,373 and $3,326,683, respectively


8,488,627


9,500,317

Deferred financing costs, net of accumulated





   amortization of $66,797 and $13,677, respectively


287,881


387,199

Goodwill


16,184,667


16,184,667

Other


784,909


823,723

       Total non-current assets


35,122,381


39,273,392


$

49,593,449

$

55,779,115

 

 

 


STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)


Liabilities and Stockholders' Equity




October 31,

2015


January 31,

2015






Current liabilities:





  Accounts payable

$

749,303

$

2,298,851

  Accrued compensation


1,104,120


865,865

  Accrued other expenses


213,130


563,838

  Current portion of long-term debt


617,657


500,000

  Deferred revenues


8,201,299


9,289,076

  Current portion of capital lease obligation


772,781


781,961

        Total current liabilities


11,658,290


14,299,591






Non-current liabilities:





  Term loans


8,029,536


9,500,000

  Warrants liability


275,914


1,834,380

  Royalty liability


2,548,965


2,385,826

  Lease incentive liability


365,140


342,129

  Capital lease obligation


126,550


582,911

  Deferred revenues, less current portion


1,495,531


964,933

  Deferred income tax liability


220,005


229,579

        Total non-current liabilities


13,061,641


15,839,758

        Total liabilities


24,719,931


30,139,349






Series A 0% Convertible Redeemable Preferred stock,
$.01 par value per share, $8,849,985 redemption value,
4,000,000 shares authorized, 2,949,995 issued and outstanding,
net of unamortized preferred stockdiscount of $1,244,994 and
$2,212,007, respectively


7,604,992


6,637,978






Stockholders' equity:





 Common stock, $.01 par value per share, 45,000,000 shares
authorized, 18,783,540 and 18,553,389
shares issued and outstanding, respectively


187,835


185,534

  Additional paid in capital


79,541,734


78,390,424

  Accumulated deficit


(62,461,043)


(59,574,170)

        Total stockholders' equity


17,268,526


19,001,788


$

49,593,449

$

55,779,115

 

 

STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)




Nine Months Ended

Oct 31,



2015


2014

Operating activities:





Net loss

$

(2,886,873)

$

(7,201,814)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:





Depreciation


930,508


670,955

Amortization of capitalized software development costs


2,332,237


2,735,990

Amortization of intangible assets


1,011,690


1,051,025

Amortization of other deferred costs


142,764


172,804

Valuation adjustment for warrants liability


(1,558,466)


(2,325,824)

Share-based compensation expense


1,858,588


1,286,145

Other valuation adjustments


206,712


119,593

Loss on disposal of property and equipment


92,448


110,710

Loss on exit of operating lease


--


234,823

Gain on early extinguishment of lease liability


(33,059)


--

Provision for accounts receivable


11,488


252,803

Deferred tax expense


(9,574)


--

Changes in assets and liabilities, net of effects of acquisitions:





Accounts and contract receivables


3,569,941


3,360,780

Other assets


411,665


(314,501)

Accounts payable


(1,505,462)


410,395

Accrued expenses


(63,498)


(801,074)

Deferred revenues


(557,179)


(2,124,790)

  Net cash provided by (used in) operating activities


3,953,930


(2,361,980)






Investing activities:





Purchases of property and equipment


(243,283)


(1,862,855)

Capitalization of software development costs


--


(503,464)

Payment for acquisition, net of cash acquired


--


(6,058,225)

  Net cash used in investing activities


(243,283)


(8,424,544)






Financing activities:





Principal repayments on term loan


(1,352,807)


(910,710)

Principal repayments on note payable


--


(300,000)

Principal payments on capital lease obligation


(602,394)


(165,115)

Recovery (payment) of deferred financing costs


2,111


(256,212)

Proceeds from exercise of stock options and stock purchase plan


225,579


438,425

  Net cash used in financing activities


(1,727,511)


(1,193,612)

Increase (decrease) in cash and cash equivalents


1,983,136


(11,980,136)

Cash and cash equivalents at beginning of period


6,522,600


17,924,886

Cash and cash equivalents at end of period

$

8,505,736

$

5,944,750

 

 


STREAMLINE HEALTH SOLUTIONS, INC.

Backlog

(Unaudited)

Table A




October 31,
2015


January 31,
2015


October 31,
2014

Streamline Health Software Licenses

$

21,533,000

$

20,888,000

$

21,103,000

Hardware and Third Party Software


200,000


244,000


126,000

Professional Services


5,951,000


7,485,000


8,095,000

Maintenance and Support


21,057,000


21,304,000


21,657,000

Software as a Service


18,738,000


22,574,000


24,928,000

    Total

$

67,479,000

$

72,495,000

$

75,909,000

 

 

 

STREAMLINE HEALTH SOLUTIONS, INC.

New Bookings

 (Unaudited)

Table B




Three Months Ended



Oct 31, 2015



Value


% of Total Bookings

Streamline Health Software licenses

$

44,000


4%

Software as a service


248,000


22%

Maintenance and support


58,000


5%

Professional services


760,000


68%

Hardware & third party software


2,000


0%

Total bookings

$

1,112,000


100%

 


 

Reconciliation of Non-GAAP Financial Measures
(Unaudited)
Table C

 

Streamline Health Solutions, Inc. (the "Company") reports its financial results in accordance with U.S. generally accepted accounting principles ("GAAP").  The Company's management also evaluates and makes operating decisions using various other measures. One such measure is adjusted EBITDA, which is a non-GAAP financial measure.  The Company defines "adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, significant non-recurring operating expenses, and transactional related expenses including: gains and losses on debt and equity conversions, associate severances and related restructuring expenses, associate inducements, professional and advisory fees, and internal direct costs incurred to complete transactions.

Non-GAAP financial information supplements and is not intended to represent a measure of performance in accordance with disclosures required by GAAP. Non-GAAP financial measures are used internally to manage the business, such as in establishing the Company's annual operating budget. The Company's management uses non-GAAP financial measures in its operating and financial decision-making because management believes these measures reflect ongoing business in a manner that allows meaningful period-to-period comparisons. Accordingly, the Company believes it is useful for investors and others to review both GAAP and non-GAAP financial measures in order to (a) understand and evaluate current operating performance and future prospects in the same manner as management does and (b) compare in a consistent manner the Company's current financial results with past financial results. The primary limitations associated with the use of non-GAAP financial measures are that these measures may not be directly comparable to the amounts reported by other companies and they do not include all items of income and expense that affect operations. The Company's management compensates for these limitations by considering the company's financial results and outlook as determined in accordance with GAAP and by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures in the below table.

Below is a table reconciling adjusted EBITDA to net loss, which is the most comparable GAAP measure.

In thousands, except per share data


Three Months Ended


Nine Months Ended



Oct 31, 2015


Oct 31, 2014


Oct 31, 2015


Oct 31, 2014

Net loss

$

(457)

$

(2,256)

$

(2,887)

$

(7,202)

    Interest expense


206


181


698


524

    Income tax expense


3


--


3


2

    Depreciation


305


310


931


671

    Amortization of capitalized software 









        development costs


774


905


2,332


2,736

    Amortization of intangible assets


337


346


1,012


1,051

    Amortization of other costs


41


50


90


121

EBITDA


1,209


(464)


2,179


(2,097)

   Share-based compensation expense


575


421


1,859


1,286

   Loss on disposal of property and equipment


58


27


92


111

   Loss on early extinguishment of debt


--


115


--


115

   Associate severances and other costs    









      relating to transactions or corporate 









      Restructuring


--


255


206


831

   Non-cash valuation adjustments to  









      assets and liabilities


(178)


(1,061)


(1,352)


(2,206)

   Transaction related professional









      fees, advisory fees and other









      internal direct costs


34


1


53


176

   Non-recurring operating expenses


--


428


--


1,491

   Other non-recurring income


--


--


(750)


--

Adjusted EBITDA

$

1,698

$

(278)

$

2,287

$

(293)

Adjusted EBITDA Margin(1)


24%


(4%)


10%


(1%)

Adjusted EBITDA per diluted share









Earnings (loss) per share - diluted

$

(0.04)

$

(0.14)

$

(0.21)

$

(0.44)

Adjusted EBITDA per adjusted diluted share (2)

$

0.08

$

(0.02)

$

0.11

$

(0.02)










Diluted weighted average shares


18,746,632


18,309,677


18,658,626


18,210,034

    Includable incremental shares — adjusted EBITDA (3)


2,234,344


--


2,493,843


--

Adjusted diluted shares


20,980,976


18,309,677


21,152,469


18,210,034

 

(1)

Adjusted EBITDA as a percentage of GAAP revenues

(2)

Adjusted EBITDA per adjusted diluted share for the Company's common stock is computed using the more dilutive of the two-class method or the if-converted method.

(3)

The number of incremental shares that would be dilutive under profit assumption, only applicable under a GAAP net loss. If GAAP profit is earned in the current period, no additional incremental shares are assumed.

 

 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/streamline-health-reports-third-quarter-2015-financial-performance-300191542.html

SOURCE Streamline Health Solutions, Inc.

News Provided by Acquire Media